Abstract
Interleukin-10 (IL-10) may have both pro- and anti-inflammatory effects in Guillain–Barré syndrome (GBS). The distribution of polymorphisms in the IL-10 gene (−1082 (G/A), −819 (T/C) and −592 (A/C)) was analysed to determine whether they could influence disease susceptibility or clinical course in GBS. The −592 CC and −819 CC genotypes associated with increased IL-10 response were more frequent in the GBS patients than in the controls ( P=0.027), but the polymorphisms did not influence the clinical course of the disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
